SS-31 10 mg
Educational recon guide for a 10 mg SS-31 (elamipretide-class) research vial. Research use only — investigational mitochondria-targeting peptide.
Vial size
Same research phases — calculator defaults and unit math match the selected vial strength.
Vial
10 mg
Your BAC water
2 mL
Concentration
5.00 mg/mL
Per unit
~50.0 mcg
Frequency
Study-design dependent (clinical development often IV infusion; secondary SC tables vary)
Route
Clinical trials often IV; secondary research-vial tables sometimes SC
Live reconstitution calculator
Defaults match this guide (10 mg + 2 mL BAC). Change water or dose and the unit tables below update automatically.
Step 1
Reconstitution
Peptide amount in the vial and how much bacteriostatic water you add.
Step 2
Your dose
Quick-select common research doses (includes 2.5 / 7.5 for dual-agonist ladders) or type any mg / mcg value.
Quick select (mg) — switch units or type any value
Suggested: 100-unit barrel (smallest that fits this draw).
Your draw
Results
Total draw
100 units
Volume
1 mL
Doses per vial
2
Syringes needed
1
Barrel
100-unit
Fits one syringe?
Yes
100-unit · 1.0 mL
Filled to 100 u
Fill one 100-unit U-100 syringe to about 100 units (1 mL).
Research cycle phases
Units and volumes recompute from your Step 1 concentration (2 mL BAC → 5.00 mg/mL · 50.0 mcg/unit). Doses below are once daily during the course — not weekly.
Standard course
Elamipretide (SS-31) clinical work has used IV infusions (e.g. mg/kg/h over hours) and other parenteral regimens. There is no simple approved SC “wellness” dose. Secondary research-vial tables sometimes discuss multi-milligram SC amounts — treat as recon math only.
| Phase | Daily dose | Units | Volume |
|---|---|---|---|
| Educational SC · 5 mg | 5 mg5,000 mcg | 100 u | 1.00 mLMulti-mg educational SC illustration |
| Educational SC · 10 mg | 10 mg10,000 mcg | 200 u | 2.00 mLHigher multi-mg educational illustration |
Alternate / higher courses
Shorter or higher daily courses discussed in research communities — not a clinical recommendation
| Phase | Daily dose | Units | Volume |
|---|---|---|---|
| Educational · 20 mg | 10 mg10,000 mcg | 200 u | 2.00 mLUpper multi-mg illustration — vial-size limited |
Supplies planner
Using the guide’s phase ladder (5 mg → 10 mg per injection (phase ladder)) over a 2-day course. Set a dose in Step 2 to plan supplies at your own amount.
Your recon
2 mL · 5.00 mg/mL
Dose in plan
Phase ladder
Syringe size
100-unit
Horizon
2-day course
SS-31 10 mg vials
2 vials
~15 mg mg total peptide over this 2-day course at 5 mg → 10 mg per injection (phase ladder). Each vial holds 10 mg.
Bacteriostatic water
2 × 3 mL or 1 × 10 mL
2 mL BAC per vial × 2 vials = 4.0 mL total. Buy as 2× 3 mL bottles or 1× 10 mL bottle (whichever you stock).
U-100 insulin syringes (100-unit)
3+ syringes
Some doses need more than one 100-unit syringe at your concentration — plan extras and split draws when the math exceeds the barrel.
Alcohol swabs & sharps
~10 swabs · 1 sharps container
Wipe vial stopper and injection site each time. Dispose needles in a proper sharps container.
Reconstitution steps
- Allow the lyophilized 10 mg SS-31 vial and bacteriostatic water to reach room temperature.
- Draw 2.0 mL bacteriostatic water (default for this guide).
- Inject BAC slowly down the inner wall of the vial — avoid blasting the powder cake.
- Gently swirl or roll until the solution is clear. Do not shake hard (foaming).
- Label with recon date and concentration (e.g. "5.0 mg/mL").
- Refrigerate at 2–8 °C (35–46 °F), protected from light. Prefer using a reconstituted multi-dose vial within ~28 days with sterile technique.
Storage
Lyophilized
Keep dry powder cold and dark when possible (−20 °C / −4 °F preferred for long-term research stock).
Reconstituted
Refrigerate at 2–8 °C (35–46 °F). Avoid freeze–thaw of the working solution. Prefer finishing within ~28 days.
- ·Write recon date and BAC volume on the label.
- ·Protect from light during storage.
- ·Discard if cloudy, particulates, or odd odor appear after reconstitution.
Protocol notes
- ·Also known as elamipretide / Bendavia in clinical development literature.
- ·Not a casual recovery peptide with validated consumer SC charts.
- ·Research use only.
Research context & considerations
SS-31 targets cardiolipin/mitochondrial membranes and has been studied in mitochondrial myopathy and other indications with mixed late-stage results. Research vials are not approved drugs.
- ·Investigational — unknown long-term research-vial safety.
- ·Not FDA-approved as a research-vial consumer product.
- ·Pregnancy out of scope.
Catalog match
SS·31 (2S10)
10mg x 10 vials · from $40